Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Loss and/or inactivation of the VHL (von Hippel-Lindau)
tumour suppressor
causes various tumours. Using a yeast two-hybrid system, we have identified the AR (androgen receptor) co-activator
UXT
(ubiquitously expressed transcript), as a VHL-interacting protein. GST pull-down and co-immunoprecipitation assays show that
UXT
interacts with VHL. In addition,
UXT
recruits VHL to the nucleus. VHL associates with the DBD (DNA-binding domain) and hinge domains of the AR and induces AR ubiquitination. Moreover, VHL interaction with the AR activates AR transactivation upon DHT (dihydrotestosterone) treatment. VHL knockdown inhibits AR ubiquitination and decreases transcriptional activation of the AR. Our data suggest that the VHL-
UXT
interaction and VHL-induced ubiquitination of AR regulate transcriptional activation of the AR.
...
PMID:Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL. 2396 93